Log in

Login to your account

Username
Password *
Remember Me

News & Events

SensiLase PAD-IQ Receives CE Mark Approval

  • Monday, 18 May 2015 19:32
  • Written by
Väsamed, Inc., a Minnesota-based medical device company, announced today that it received CE Mark approval to market its SensiLase PAD-IQ® System for the diagnostic assessment of peripheral tissue perfusion using SPP and PVR in Europe. PAD-IQ’s approval was supported by years of quality and compelling…
Thank you for visiting our booth at Korean Foot and Ankle Society, 2015, Diabetic Foot Symposium, last week. Pictured from left to right are PAD-IQ market, sales and product managers, Mr. Gene Lee, Ms. Hyun Jin Yeo, and Mr. Tae Hoon Yoon.

First day #SAWC

  • Friday, 01 May 2015 16:28
  • Written by
First day #SAWC and VÄSAMED Booth 850 is packed with wound specialists learning about angiosome guided SPP. 

#SAWC/WHS Spring 2015

  • Thursday, 30 April 2015 13:19
  • Written by
#SAWC/WHS Spring 2015 Väsamed Inc. Booth 850, Conversation with Authors, Fri, May 1 at 7:15PM Meet Audrey Moyer-Harris BSN RN CWCN MBA Utilization Advanced Tech for Screening and Treating PAD: Healing Wounds and Preventing Amputations. Ms. Moyer-Harris will also be at Väsamed’s Booth on Friday and Saturday to…

UCSF 2015 Vascular Symposium

  • Monday, 27 April 2015 15:13
  • Written by
Pictured with PAD-IQ and Väsamed Regional Manager, Emily Fjerstad, at UCSF 2015 Vascular Symposium, are Dr. Michael Conte, Chief, Vascular & Endovascular Surgery, Co-Director, UCSF Heart and Vascular, and Medical Director, Vascular Noninvasive Laboratory and Dr. Michael Palmer.